Evolution and Novo Nordisk were picked up due to a UK investigation into the license in the country and a study disappointment, respectively.
"Evolution fell double-digit on the news that the UK gambling authority is investigating the company's license in the country. Retail investors apparently believe that the market's reaction to the news was clearly exaggerated and net bought in the fall. Even before that, the stock was widely bought," says economist Frida Bratt.
The fall in Novo Nordisk's share price was a cold shower for existing shareholders, but also an opportunity for many to step in at lower levels.
"Confidence in Novo Nordisk going forward seems to be firmly established on the part of private savers - at Nordnet, there was a buying party in the share the same day it fell," says Bratt.
One of the most sold shares was the US electric car manufacturer Tesla, which has performed strongly after the presidential election. "Savers are choosing to take profits," says Bratt.
Most bought | Most sold |
Investor | Ericsson |
Novo Nordisk | Camurus |
Apotea | Neobo Real Estate |
Evolution | Tesla |
Volvo | Norwegian |
SSAB | Electrolux |
Astra Zeneca | Cint |
Nibe | Apple |
Axfood | Byggmax |
Handelsbanken | Boliden |